Nitrosamine carcinogenesis: Rodent assays, quantitative structure- activity relationships, and human risk assessment

Drug Metabolism Reviews

Volumn 29, Issue 4, 1997, Pages 1055-1078

  Lewis, D F V ^a   Brantom, P G ^b   Ioannides, C ^a   Walker, R ^a   Parke, D V ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b BIBRA INTERNATIONAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450; NITROSAMINE;

CARCINOGEN TESTING; CARCINOGENESIS; CONFERENCE PAPER; HUMAN; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RISK ASSESSMENT;

EID: 0031425484     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539709002243     Document Type: Conference Paper

References (59)

1. P. H. Magee and J. M. Barnes, Br. J. Cancer, 10, 114-122 (1956).
2. H. Bartsch and R. Montesano, Carcinogenesis, 5, 1381-1393 (1984).
3. S. R. Tannenbaum, Lancet, 1, 629-631 (1983).
4. B. Spiegelhalder, G. Eisenbrand, and R. Preussman, Oncology, 37, 211-216 (1980).
5. P. Bogovski and S. Bogovski, Int. J. Cancer, 27, 471-474 (1981).
6. P. I. Reed, K. Haines, P. L. R. Smith, F. R. House, and C. L. Walters, Lancet, 2, 550-552, (1981).
7. L. M. Anderson, A. Giner-Sorolla, I. M. Haller, and J. M. Budinger, Cancer Res., 45, 3561-3566 (1985).
8. L. M. Anderson, T. Enomoto, A. O. Perantoni, C. W. Riggs, R. M. Kovatch, C. D. Reed, A. Giner-Sorolla, and J. M. Rice, Carcinogenesis, 10, 2009-2013 (1989).
9. G. Wenke, A. Rivenson, and D. Hoffman, Carcinogenesis, 5, 1137-1140 (1984).
10. H. W. Haverkos, A. N. Kopste, H. Wilson, and D. P. Drotman, Environ. Health Perspect., 102, 858-861 (1994).
11. S. R. Tannenbaum, in Safety Evaluation of Nitrosatable Drugs and Chemicals (G. G. Gibson and C. Ioannides, eds.), Taylor and Francis, London, 1981, pp. 234-249.
12. P. Brantom, Ph.D. thesis, University of Surrey, UK, 1983.
13. M. Poulsen, D. Spanger, and G. H. Loew, Mol. Toxicol., 1, 35-47 (1987).
14. C. S. Yang, J.-S. H. Yoo, H. Ishizaki, and J. Hong, Drug Metab. Rev., 22, 147-159 (1990).
15. H. Yamazaki, Y. Oda, Y. Funae, S. Imaoka, Y. Inui, F. P. Guengerich, and T. Shimada, Carcinogenesis, 13, 979-985 (1992).
16. M. J. J. Ronis, K. O. Lindros, and M. Ingelman-Sundberg, in Cytochromes P450: Metabolic and Toxicological Aspects (Costas Ioannides, ed.), CRC Press, New York, 1996, pp. 211-239.
17. S. A. Wrighton and J. C. Stevens, Crit. Rev. Toxicol., 22, 1-47 (1992).
18. J. K. Piotrowski and D.V. Parke, Acta Pol. Toxicol., 4, 1-14 (1996).
19. W. Lijinsky, Mol. Toxicol., 1, 107-119 (1987).
20. A. J. Streeter, R. W. Nims, P. R. Sheffels, Y.-H. Heur, C. S. Yang, B. A, Mico, C. T. Gombar, and L. K. Keefer, Cancer Res., 50, 1144-1150 (1990).
21. K. E. Appel, M. Wiessler, M. Schoepke, C. S. Ruhl, and A. G. Hildebrandt, Carcinogenesis, 7, 659-663 (1986).
22. G. H. Loew, M. T. Poulsen, D. Spangler, and E. Kirkjan, Int. J. Quant. Chem., Quant. Biol. Symp., 10, 201-213 (1983).
23. B. Petit, R. Potenzone, A. J. Hopfinger, G. Klopman, and M. Shapiro, in Computer-Assisted Drug Design (E. C. Olson and R. E. Christoffersen, eds.), American Chemical Sociey Symposium Series 112, American Chemical Society, Washington, DC, 1979, pp. 553-581.
24. H. Druckrey, UICC Monograph Series Vol. 7, Potential Carcinogenic Hazards front Drugs (R. Truhaut, ed.), Springer, Berlin, 1967.
25. J. S. Wishnok, M. C. Archer, A. S. Edelman, and W. M. Rand, Chem.-Biol. Interact., 20, 43-54 (1978).
26. J. G. Vinter, A. Davis, and M. R. Saunders, J. Comput.-Aided Mol. Design, 1, 31-51 (1987).
27. B. Krebs and J. Mandt, Chem. Berichte, 108, 1130-1137 (1975).
28. D. F. V. Lewis, Int. J. Quantum Chem., 33, 305-321 (1988).
29. D. F. V. Lewis, C. Ioannides, and D. V. Parke, Mutat. Res., 291, 61-77 (1993).
30. D. V. Parke, Environ. Health Perspect., 102, 852-853 (1994).
31. D. F. V. Lewis, C. Ioannides, and D. V. Parke, Xenobiotica, 24, 401-408 (1994).
32. J. A. Swenberg, D. G. Hoel, and P. N. Magee, Cancer Res., 51, 6409-6414 (1991).
33. R. Peto, R. Gray, P. Brantom, and P. Grasso, Cancer Res., 51, 6415-6451 (1991).
34. D. F. V. Lewis, C. Ioannides, and D. V. Parke, Chem.-Biol. Interact. , 64, 39-60 (1987).
35. D. F. V. Lewis, C. Ioannides, and D. V. Parke, Toxicol. Lett., 45, 1-13 (1989).
36. G. Bellec, T. Goasduff, Y. Dreano, J.-F. Menez, and F. Berthou, Cancer Lett., 100, 1115-123 (1996).
37. R. J. Gryglewski, in Food, Nutrition and Chemical Toxidty (D. V. Parke, C. Ioannides, and R Walker, eds.), Smith-Gordon Nishimura, London, 1993, pp. 181-187.
38. M. A. Marletta, M. A. Tayeh, and J. M. Hevel, Biofactors, 2, 219-225 (1990).
39. C. D. Leaf, J. S. Wishnok, J. P. Hurley, W. D. Rosenblad, J. G. Fox, and S. R. Tannenbaum, Carcinogenesis, 11, 855-858 (1990).
40. R. Dagan, E. Zaltztein, and R. Gorodischer, Eur. J. Paediatr., 147, 87-89 (1988).
41. C. D. Leaf, J. S. Wishnok, and S. R. Tannenbaum, Carcinogenesis, 12, 537-539 (1991).
42. MAFF, Food Surveillance Paper No. 32, HMSO, London, 1992.
43. G. Witz, Proc. Soc. Exp. Biol. Med., 675-682 (1991).
44. C. Ioannides and D. V. Parke, Drug Metab. Rev., 22, 1-85 (1990).
45. M. Stiborová, E. Frei, H. H. Schmeiser, M. Wiessler, and P. Anzenbacher, Cancer Lett., 63, 53-59, (1992).
46. C. Ioannides, D. F. V. Lewis, and D. V. Parke, Eur. J. Cancer Prevent. 2, 275-282 (1993).
47. C. Ioannides and D. V. Parke, Drug Metab. Rev., 25, 485-501 (1993).
48. Y. Y.Tu and C. S. Yang, Arch. Biochem. Biophys., 242, 32-40 (1985).
49. J. S-H. Yoo, H. Ishizaki, and C. S. Yang, Carcinogenesis, 11, 2239-2243 (1990).
50. K. E. Appel, H. H. Ruf, B. Mahr, M. Schwarz, R. Rickart, and W. Kunz, Chem.-Biol. Interact., 28, 17-33 (1979).
51. T. Kawanishi, Y. Ohno, A. Takanaka, S. Kawano, Y. Yamazoe, R. Kato, and Y. Omori, Arch. Toxicol., 66, 137-142 (1992).
52. C. L. Crespi, B. W. Penman, J. A. E. Leakey, M. P. Arlotto, A. Stark, A. Parkinson, T. Turner, D. T. Steimel, K. Rudo, R. L. Davies, and R. Lagenbach, Carcinogenesis, 11, 1293-1300 (1990).
53. P. T. Liu, P. A. Kentish, A. M. Symons, and D. V. Parke, Toxicology, 80, 37-49 (1993).
54. F. P. Guengerich, D.-H. Kim, and M. Iwasaki, Chem. Res. Toxicol., 4, 168-179 (1991).
55. M. Ahotupa, V. Bussachini-Griot, J.-C. Béréziat, A.-M. Camus, and H. Bartsch, Biochem. Biophys. Res. Commun., 146, 1047-1054 (1987).
56. D. V. Parke and C. Ioannides, in Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons (D. E. Stevenson, R. M. McClain, J. A. Popp, J. A. Slaga, J. M. Ward, and H. C. Pilot, eds.), Alan R. Liss, New York, 1990, pp. 215-230.
57. A. E. Pegg, Cancer Res., 50, 6119-6129 (1990).
58. B. Ames and L. S. Gold, Mutat. Res., 250, 3-16 (1991).
59. B. Halliwell, Nutr. Rev., 52, 253-265 (1994).